Rockwell Medical, Inc.

corporate_fare Company Profile

Rockwell Medical, Inc.

RMTI·NASDAQ·Life Sciences·CIK 0001041024

Rockwell Medical is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products to dialysis providers globally. The company supplies liquid and dry, acid and bicarbonate concentrates for dialysis patients within the United States. Its registered trademarks include CitraPure®, Dri-Sate®, RenalPure®, and SteriLyte®.

Rockwell Medical, Inc. (NASDAQ:RMTI) is a publicly traded company in the Life Sciences sector. Wiseek monitors RMTI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

Rockwell Medical Regains Nasdaq Compliance After Reverse Split (2026-07-20)
Rockwell Medical Resolves Nasdaq Bid Price Deficiency, Regains Full Compliance (2026-07-20)
Rockwell Medical Finalizes 1-for-10 Reverse Stock Split, Effective July 1 (2026-06-29)
Rockwell Medical Announces 1-for-10 Reverse Stock Split to Maintain Nasdaq Listing (2026-06-29)
Shareholders Approve Reverse Stock Split to Maintain Nasdaq Listing (2026-06-15)

Financial Snapshot

Fiscal year ended December 31, 2025

Revenue

$69.26M

Net Income

-$5.31M

Diluted EPS

-$0.15

Op. Cash Flow

-$659K

Free Cash Flow

-$1.2M

Gross Profit

$11.7M

Operating Income

-$4.69M

Cash & Equivalents

$10.71M

Total Debt

$8.83M

Debt / Equity

0.24×

Net Margin

-7.7%

Shares Outstanding

39.41M sh

Source: 10-K · filed 2026-03-26 · accession 0001628280-26-021186

show_chartPrice Chart

Loading chart...

feed RMTI - Latest Insights

Filing Type

Date Range

RMTI

Jul 20, 2026, 6:23 AM EDT

Source: Wiseek News

Importance Score:

Rockwell Medical Regains Nasdaq Compliance After Reverse Split

Price at Filing: $6.13

Real-time Price: $6.99

Change: +$0.865 (+14%)

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

Jul 20, 2026, 6:22 AM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Resolves Nasdaq Bid Price Deficiency, Regains Full Compliance

Price at Filing: $6.13

Real-time Price: $6.99

Change: +$0.865 (+14%)

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

Jun 29, 2026, 6:17 AM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Finalizes 1-for-10 Reverse Stock Split, Effective July 1

Price at Filing: $0.6013

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Neutral

View Wiseek Article

RMTI

Jun 29, 2026, 6:00 AM EDT

Source: Dow Jones Newswires

Importance Score:

Rockwell Medical Announces 1-for-10 Reverse Stock Split to Maintain Nasdaq Listing

Price at Filing: $0.6449

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Neutral

View Wiseek Article

RMTI

Jun 15, 2026, 4:27 PM EDT

Filing Type: 8-K

Importance Score:

Shareholders Approve Reverse Stock Split to Maintain Nasdaq Listing

Price at Filing: $0.656

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Negative

View Wiseek Article

RMTI

May 08, 2026, 5:00 PM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency

Price at Filing: $0.8338

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Negative

View Wiseek Article

RMTI

May 07, 2026, 6:59 AM EDT

Filing Type: 10-Q

Importance Score:

Rockwell Medical Reports Significantly Improved Operating Cash Flow and 12-Month Liquidity Runway

Price at Filing: $0.830

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

May 07, 2026, 6:16 AM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Projects 2026 Profitability and Positive Cash Flow Amidst Operational Streamlining

Price at Filing: $0.807

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

May 07, 2026, 6:01 AM EDT

Source: Dow Jones Newswires

Importance Score:

Rockwell Medical Projects FY26 Revenue Between $70M and $75M

Price at Filing: $0.807

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Neutral

View Wiseek Article

RMTI

Apr 30, 2026, 6:59 AM EDT

Filing Type: DEF 14A

Importance Score:

Rockwell Medical Finalizes Reverse Stock Split Proposal for Nasdaq Compliance, Retains High Dilution Potential

Price at Filing: $0.918

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Negative

View Wiseek Article

RMTI

Apr 20, 2026, 4:09 PM EDT

Filing Type: PRE 14A

Importance Score:

Shareholders to Vote on Reverse Stock Split to Maintain Nasdaq Listing; Potential for Over 4000% Dilution Post-Split

Price at Filing: $0.9387

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Negative

View Wiseek Article

RMTI

Mar 26, 2026, 7:30 AM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Updates Investor Presentation with Long-Term Financial Framework and No Further Fundraising Needs

Price at Filing: $0.918

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

Mar 26, 2026, 7:01 AM EDT

Filing Type: 10-K

Importance Score:

Rockwell Medical Reports Steep Revenue Decline, Operating Loss, and Negative Cash Flow in 2025 Annual Report

Price at Filing: $0.970

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Negative

View Wiseek Article

RMTI

Mar 26, 2026, 6:10 AM EDT

Filing Type: 8-K

Importance Score:

Rockwell Medical Reports Q4 & Full-Year 2025 Results: Achieves Adjusted EBITDA Profitability, Boosts Cash Position

Price at Filing: $0.797

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

Jan 20, 2026, 6:32 AM EST

Filing Type: 8-K

Importance Score:

Rockwell Medical Reports Strong Preliminary Q4 & Full-Year 2025 Results with Positive Cash Flow and Improved Cash Position

Price at Filing: $1.08

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

RMTI

Jan 05, 2026, 6:33 AM EST

Filing Type: 8-K

Importance Score:

Rockwell Medical Extends DaVita Agreement with Favorable Product Price Increase

Price at Filing: $0.8875

Real-time Price: $6.99

Change: Reverse Stock Split

Market Cap: $27.59M

Sentiment: Positive

View Wiseek Article

corporate_fare Company Profile